Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: February 2012
Research and Markets: Medical Devices and Equipment Market in Iran
Posted: Published on February 19th, 2012
DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/9c3351/medical_devices_an) has announced the addition of the "Medical Devices and Equipment Market in Iran" report to their offering. “Medical Devices and Equipment Market in Iran” Iran Medical Equipment: A comprehensive report on Iran's Medical Equipment & Hospital Supplies, suitable for the manufacturers and distributors who would like to enter and/or expand in the market. The report includes data and statistics on imported and locally manufactured equipment/products as well as information on how to participate in tenders and projects. The 5 major categories covered are: 1. Diagnostic imaging system 2. Artificial Internal Organ Apparatus & Clinical Equipment 3. Clinical test equipment (including measuring and monitoring system) 4. Therapeutic Equipment 5. Hospital Supplies Key Topics Covered: Introduction About the Report Product Categories under Investigation Country Overview Healthcare Policy and System Government Policy Briefing of Medical and Insurance System Public Private Overview of Medical Equipment Market Market Size and Forecast Import Trends Patterns of Best Selling Products Status of Foreign Companies/Products Tier1 Brands Others Main Projects/Plans Public Sector Private Sector Key Basic Information in Order to Penetrate into the Market Market Characteristics Distribution System Procurement Method Market Entry Method Main Events Trade Fairs and Their Effectiveness Other Tender Opportunities Import/Sales … Continue reading
Posted in Hormone Replacement Therapy
Comments Off on Research and Markets: Medical Devices and Equipment Market in Iran
'Wild west' approach to claiming the oceans' genetic resources must end: researchers
Posted: Published on February 19th, 2012
"The reservoir of genetic diversity contained in the oceans' microbial life is a huge potential source of natural products and genes with applications in medicine, food development and bio-energy," says Curtis Suttle, an expert on marine virology and microbiology at the University or British Columbia and member of the panel. "The question is whether they fall under a regime of 'freedom of the high seas' which allows the discoverer to keep what they find, or under a regime of 'the common heritage of mankind' which would require benefits from the use of genetic resources to be equitably shared amongst countries." Marine genetic resources discovered in coastal waters are subject to bilateral 'benefit sharing' under international agreements currently being ratified. But no such agreements govern the patenting and commercialization of proteins and genes harvested from international waters. "Marine genetic resources within national jurisdiction are subject to requirements for benefit sharing under the Nagoya Protocol, and it is time to consider a parallel agreement for areas beyond national jurisdiction," says panelist Marjo Vierros with the United Nations University (UNU). The UNU is the academic arm of the United Nations system. "Any agreement should include mechanisms to support marine scientific research and invention … Continue reading
Comments Off on 'Wild west' approach to claiming the oceans' genetic resources must end: researchers
Alzheimer's drugs may have adverse side effects
Posted: Published on February 19th, 2012
Public release date: 18-Feb-2012 [ | E-mail | Share ] Contact: Marla Paul marla-paul@northwestern.edu 312-503-8928 Northwestern University CHICAGO --- Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain. The findings, from the scientist whose original research led to the drug development, are published in the journal Molecular Neurodegeneration and will be presented Saturday, Feb. 18, at the 2012 annual meeting for the American Association for the Advancement of Science in Vancouver. "Let's proceed with caution," said Robert Vassar, professor of cell and molecular biology at Northwestern University Feinberg School of Medicine. "We have to keep our eyes open for potential side effects of these drugs." Ironically, he says, the drugs could impair memory. The drugs are designed to inhibit BACE1, the enzyme Vassar originally discovered that promotes the development of the clumps of plaque that are a hallmark of Alzheimer's. BACE1 acts as a molecular scissors, cutting up and releasing proteins that form the plaques. Thus, drug developers believed … Continue reading
Posted in Drug Side Effects
Comments Off on Alzheimer's drugs may have adverse side effects
Qnexa Obesity Drug – FDA Concerned About Long-term Side Effects
Posted: Published on February 19th, 2012
Editor's Choice Main Category: Obesity / Weight Loss / Fitness Also Included In: Regulatory Affairs / Drug Approvals Article Date: 18 Feb 2012 - 11:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient / Public: 4 (1 votes) Healthcare Prof: The FDA has expressed concerned regarding obesity drug Qnexa - a combination of phentermine and topiramate - and what associations there may be between long-term usage and birth defect risks, as well as its impact on the heart. The Food and Drug Administration (FDA) is reviewing Qnexa again, after turning down its submission for approval two years ago ("FDA Turns Down Weight Loss Drug Qnexa, But Makers See Short Timeline For Approval"). There is an FDA Advisory Panel (Endocrinologic and Metabolic Drugs Advisory Committee) meeting on 22 February. The Panel will look at 2-years' worth of clinical data. When Qnexa was last reviewed, the Agency only had 1-year's worth of data to look at. The Advisory Panel consists of experts, none of whom work for the FDA. They will have to discuss and vote on whether to recommend supporting or declining the obesity drug after carrying out an overall benefit-risk assessment. The Panel's … Continue reading
Posted in Drug Side Effects
Comments Off on Qnexa Obesity Drug – FDA Concerned About Long-term Side Effects
Burglar with 23 felonies could get less than four years in prison
Posted: Published on February 19th, 2012
Amanda Tucker was a drug addict with a clear, calculated pattern of victimizing the elderly, police say. Two of her victims were 90 and 94, both suffering from dementia. As they stood by in their residence last fall, Tucker stole their financial instruments and a pair of earrings. Earlier at the Mirabella Retirement Community in Seattle, she walked into the room where an 87-year-old man was being cared for by his daughter. Tucker claimed she was looking for her grandmother's apartment, but left with the man's credit cards. Her crime spree led to 23 felony counts, and Tucker pleaded guilty on Jan. 23. But because Tucker is eligible for a drug offender sentencing alternative she could face only 36.75 months in jail, which could also be reduced by good behavior. King County Superior Court Judge Michael C. Hayden will decide Friday afternoon if she'll get that penalty or the maximum seven years in prison that police and prosecutors are hoping for. "The defendant's actions are not the actions of a drug addict who acts on impulse to feed her drug habit," Deputy Prosecuting Attorney Mafé Rajul wrote in a sentencing memo. "Instead, her criminal actions are those of someone who … Continue reading
Posted in Drug Dependency
Comments Off on Burglar with 23 felonies could get less than four years in prison
New Prostate Cancer Treatment Drugs Could Pack Double Punch
Posted: Published on February 19th, 2012
NEW YORK, Feb. 17, 2012 /PRNewswire/ -- The arsenal of prostate cancer treatments for men with advanced prostate cancer may soon be strengthened as the FDA prioritizes the review of both Ra-223 and MDV3100 for treating metastatic castration-resistant prostate cancer (CRPC). Based on positive, independent research of each drug, better survival rates and improved bone health for patients with late-stage prostate cancer may be within reach. (Photo: http://photos.prnewswire.com/prnh/20120217/NY55303 ) Dr. David Samadi is Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center and a leading robotic surgery expert and PSA test advocate. He commended the efforts behind these advancements by saying, "I'm encouraged to see advanced prostate cancer treatment drugs that may not only extend life, but do so with improved patient health. That's the key – prolonging life with quality." Previous drug therapies, such as Provenge or Zytiga, have proven to extend survival rates, though do not offer additional benefits to the patient. The drug Radium-223 chloride, also known as Ra-223 or Alpharadin, delivers radiation to the bone and the prostate cancer tumor. In trial, the drug improved patient survival by an average of three months. In addition, patients undergoing … Continue reading
Posted in Drugs
Comments Off on New Prostate Cancer Treatment Drugs Could Pack Double Punch
Drugs education link to Scientology church
Posted: Published on February 19th, 2012
KIRSTY JOHNSTON A controversial Church of Scientology drug-awareness programme has received government funding to spread its unorthodox views through schools and community groups. In the past six months, drug-free ambassadors linked to the church have circulated 130,000 drug education booklets around New Zealand, paid for in part by the Department of Internal Affairs' Community Organisations Grant Scheme. The ambassadors claim at least 18 community groups – including their "partners" the Maori Wardens – plus at least seven high schools, endorse and use the materials. Advice offered in the pamphlets is based on research by Scientology's controversial founder, LRon Hubbard, who did not believe in medical drugs or psychiatry but instead in purging oneself of painful experiences to gain immortality. Ross Bell, executive director of the New Zealand Drug Foundation, warned that the group's information was flawed pseudo-science and could prove harmful to youth. "This kind of quackery should not be in our schools – we are talking about young people's lives," he said. "Drug and alcohol issues are complex and therefore we need well-qualified, proper, evidence-based support advice and information." Bell said Scientology's views on mental health were not based on science, and had been discredited "time and time again" … Continue reading
Posted in Drugs
Comments Off on Drugs education link to Scientology church
Study shows brain differences in kids with autism
Posted: Published on February 18th, 2012
(AP) No one is exactly sure what causes autism, but scientists may have found a way to spot the disorder in young children even earlier than before. A new study, out Friday in the American Journal of Psychiatry, found that children who develop autism have abnormalities on brain scans that can be detected long before obvious symptoms advanceSOMETHING HERE. CBS News medical correspondent Dr. Jonathan LaPook reported that children with autism are rarely diagnosed before the age of two, but scientists have long wondered if problems in the brain may start earlier. The study followed 92 infants from six months old until they were 2. All were high risk because their siblings had autism. Twenty-eight of them were eventually diagnosed with the disorder. When looking back at their brain scans, scientists noticed differences. A special type of MRI scan shows developed nerve connections of a normal brain. When compared to a scan of a brain of an infant with autism, the pattern is significantly different. "During infancy, it's a time when an infant is organizing their brain, the wiring is rapidly developing," said Dr. Joseph Piven, who led the study. "We were able to detect changes in that wiring or … Continue reading
Comments Off on Study shows brain differences in kids with autism
Study: Brain scans detect early signs of autism
Posted: Published on February 18th, 2012
(AP) No one is exactly sure what causes autism, but scientists may have found a way to spot the disorder in young children even earlier than before. A new study, out Friday in the American Journal of Psychiatry, found that children who develop autism have abnormalities on brain scans that can be detected long before obvious symptoms advanceSOMETHING HERE. CBS News medical correspondent Dr. Jonathan LaPook reported that children with autism are rarely diagnosed before the age of two, but scientists have long wondered if problems in the brain may start earlier. The study followed 92 infants from six months old until they were 2. All were high risk because their siblings had autism. Twenty-eight of them were eventually diagnosed with the disorder. When looking back at their brain scans, scientists noticed differences. A special type of MRI scan shows developed nerve connections of a normal brain. When compared to a scan of a brain of an infant with autism, the pattern is significantly different. "During infancy, it's a time when an infant is organizing their brain, the wiring is rapidly developing," said Dr. Joseph Piven, who led the study. "We were able to detect changes in that wiring or … Continue reading
Comments Off on Study: Brain scans detect early signs of autism
Autism bill could treat hundreds of children in Utah
Posted: Published on February 18th, 2012
First published Feb 17 2012 06:33PM Updated 6 hours ago Updated Feb 17, 2012 10:38PM HB272 • A bill to fund treatment for approximately 750 young children with autism moved forward Friday after being approved by the House Health and Human Services Committee. The bill has been refined to focus on children between the ages of 2 and 6 with up to 500 children on Medicaid, several hundred who are not on Medicaid (and may be privately insured) and several dozen who are on the Public Employees’ Benefit and Insurance Program. Elected officials are in negotiation with insurance companies about the possibility of contributing to funding. Rep. Ronda Rudd Menlove, R-Garland, the sponsor of HB272, has asked for $6 million in Medicaid dollars. “Even at 750 we still would be missing some children,” she said, noting that Utah’s population of autistic children is more than 2,000. Laura Anderson, with the Autism Council of Utah, said her group supported this latest compromise, emphasizing that treatment for young children has been proven to work. Without it, “we are creating a generation of children who will need services far beyond public education,” she said. Julia Lyon See the rest here: Autism bill could … Continue reading
Comments Off on Autism bill could treat hundreds of children in Utah